Leiters Awarded a National Group Purchasing Agreement by Intalere Leiters, a trusted FDA-registered 503B outsourcing provider of high-quality hospital and ophthalmology compounded sterile preparations and
COMPOUNDING HEALTH™ Leiters is a trusted FDA-registered 503B outsourcing provider of high-quality hospital and ophthalmology compounded sterile preparations. We are committed to providing healthcare professionals
Product & Service Providers in: ADMIXTURE COMPOUNDING SERVICES (503B OUTSOURCING FACILITIES) 340B RESOURCES IV/INFUSION ADHERENCE As Seen In: View Leiters’ Ad:
Your journey to better medicine begins here. With increasing regulatory pressure and the need to reduce costs while improving the patient experience, access to quality
Helping You Deliver Better Medicine to More People. With increasing regulatory pressure and drug shortages, access to quality medicine is more important than ever. Leiters
Helping You Deliver Better Medicine to More People. With increasing regulatory pressure and drug shortages, access to quality medicine is more important than ever. Leiters
Leiters Awarded a Group Purchasing Agreement by Comprehensive Pharmacy Services Leiters announced today that it has entered into a strategic arrangement with the newly reorganized
Leiters, a trusted FDA-registered 503B outsourcing provider of high-quality compounded sterile preparations, continues to closely monitor the evolving COVID-19 situation and the potential healthcare drug
DENVER, Feb. 26, 2020 — Leiters, a trusted FDA-registered 503B provider of high-quality compounded sterile preparations, announced today its continued commitment to provide the highest
Your Journey to Better Medicine Begins Here The world of healthcare is evolving. With increasing regulatory pressure and the need to reduce costs while improving
Stay informed on pharmacy supply chain news, market trends, and product releases by subscribing to RXinsider’s emails, newsletters, and publications. If building awareness with pharmacy management is part of your marketing strategy, consider advertising with RXinsider.
